Confirmed Attending Companies Include:
|
A C Binder Corp.
AbbVie, Inc. Abingworth LLP Agent Capital, LLC Alpha Bronze Amorsa Therapeutics, Inc. Angel Investor APS International Arbor Pharmaceuticals, Inc. Arix Bioscience ASDERA Assembly Biosciences Athyrium Capital Management Avanir Pharmaceuticals Avicenna Ventures Axial Biotherapeutics Bigger Capital Fund, LP Bishop Capital Management Boehringer Ingelheim Venture USA, Inc. BrainStorm Cell Therapeutics, Inc. Brendan E. Cryan & Co. LLC Cambridge Cognition Ltd. Cantabio Pharmaceuticals, Inc. CastleRock Management CBT Advisors Cipla New Ventures Clarus Ventures, LLC Cognition Therapeutics, Inc. Cortexyme CureDuchenne Ventures Dabar Investment Associates Daiichi Sankyo, Inc. Dawson James Securities, Inc. Deca Ventures Defined Health, a Cello Health business Delwar Capital Edison Investment Research Eli Lilly and Co. Embera NeuroTherapeutics, Inc. Enso Ventures Erydel ESC Advisors Exscientia Ltd. F. Hoffmann La Roche Ltd. First Republic Investment Management |
Flagship Ventures
Fountain Healthcare Partners Fraser Finance FreeMind Group Goodwin Procter LLP Hercules Technology Growth Capital, Inc. Hereditary Neuropathy Foundation ICR, Inc. Johnson & Johnson Katalyst Securities, LLC KemPharm, Inc. K-PAX Pharmaceuticals, Inc. Landmark Family Office Lauren Sciences LLC & Maya Sciences LLC Lexington Capital Management Little Gem Life Sciences Lonza Walkersville, Inc. Loop Capital Markets Lysosomal Therapeutics, Inc. M3 Biotechnology, Inc. Mavericks Capital MedPro Investors, LLC Merck & Co., Inc. Mergermarket Mid Atlantic Bio Angels Minoryx Therapeutics S.L. Mizuho Bank Momentum Biotech MP Healthcare Venture Management, Inc. NeuroRx, Inc. NeuroTherapia, Inc. Neurotrope Bioscience, Inc. New Enterprise Associates New Frontier Capital, LP New York Ventures Nexeon Medsystems, Inc. NI Research, Inc. Noble Life Science Partners NSIP LLC Occidental Group Oppenheimer & Co. Inc. Origenis GmbH Oryzon Genomics SA P4G Capital Park Avenue Capital |
Parkfield Fund LLC
Perseverance Capital Pfizer, Inc. Pharmasum Therapeutics AS PJT Partners Probiodrug AG ProMIS™ Neurosciences, Inc. ProPhase Purdue Pharma L.P. Quartet Medicine Queen Mary University London Raman Health Technologies, S.L. Remiges Ventures Sachs Associates Ltd. SalubRx Therapeutics, Inc. Sanofi Shadow Lake Group, Inc. Shaw Strategic Capital LLC Stanphyl Capital SternAegis Ventures Sternberg Investments Sunovion Pharmaceuticals, Inc. SunRegen Healthcare AG Syncrosome Syzygy Therapeutics T3D Therapeutics, Inc. Tanaka Capital Management The Alzheimer's Drug Discovery Foundation The Astrologers Fund, Inc. The Center for Performance Investing The Michael J. Fox Foundation TikoMed AB TS Family Office Union Square Advisors vasopharm GmbH Vector Resource Funds Vista Point Capital WallachBeth Capital WBB Securities, LLC Wells Fargo Advisors WestPark Capital Wotczak Group YLM2012 Trust Yorkville Advisors, LLC Yumanity Therapeutics YunTai Fund USA Office |